149 related articles for article (PubMed ID: 19181558)
1. Impact of combined and progestogen-only contraceptives on bone mineral density.
Sarfati J; de Vernejoul MC
Joint Bone Spine; 2009 Mar; 76(2):134-8. PubMed ID: 19181558
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception.
Wanichsetakul P; Kamudhamas A; Watanaruangkovit P; Siripakarn Y; Visutakul P
Contraception; 2002 Jun; 65(6):407-10. PubMed ID: 12127638
[TBL] [Abstract][Full Text] [Related]
3. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
Cromer BA; Stager M; Bonny A; Lazebnik R; Rome E; Ziegler J; Debanne SM
J Adolesc Health; 2004 Dec; 35(6):434-41. PubMed ID: 15581522
[TBL] [Abstract][Full Text] [Related]
4. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health.
Petitti DB; Piaggio G; Mehta S; Cravioto MC; Meirik O
Obstet Gynecol; 2000 May; 95(5):736-44. PubMed ID: 10775740
[TBL] [Abstract][Full Text] [Related]
5. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
Gai L; Jia Y; Zhang M; Gai P; Wang S; Shi H; Yu X; Liu Y
Contraception; 2012 Oct; 86(4):332-6. PubMed ID: 22364818
[TBL] [Abstract][Full Text] [Related]
6. Overview of the relationship between use of progestogen-only contraceptives and bone mineral density.
Banks E; Berrington A; Casabonne D
BJOG; 2001 Dec; 108(12):1214-21. PubMed ID: 11843382
[TBL] [Abstract][Full Text] [Related]
7. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women.
Naessen T; Olsson SE; Gudmundson J
Contraception; 1995 Jul; 52(1):35-9. PubMed ID: 8521712
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraception and bone metabolism: a systematic review.
Nappi C; Bifulco G; Tommaselli GA; Gargano V; Di Carlo C
Contraception; 2012 Dec; 86(6):606-21. PubMed ID: 22717184
[TBL] [Abstract][Full Text] [Related]
10. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
11. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Levine JP
J Fam Pract; 2004 Nov; 53(11):904-13. PubMed ID: 15527729
[No Abstract] [Full Text] [Related]
12. Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross-sectional study of Thai women.
Taneepanichskul S; Intaraprasert S; Theppisai U; Chaturachinda K
Contraception; 1997 Sep; 56(3):153-5. PubMed ID: 9347205
[TBL] [Abstract][Full Text] [Related]
13. Use of hormonal contraception in adolescents: skeletal health issues.
Tolaymat LL; Kaunitz AM
Curr Opin Obstet Gynecol; 2009 Oct; 21(5):396-401. PubMed ID: 19491681
[TBL] [Abstract][Full Text] [Related]
14. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Godsland IF; Crook D; Devenport M; Wynn V
Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormonal contraceptives on bone mineral density.
Cromer BA
Drug Saf; 1999 Mar; 20(3):213-22. PubMed ID: 10221851
[TBL] [Abstract][Full Text] [Related]
16. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate.
Modesto W; Bahamondes MV; Bahamondes L
J Womens Health (Larchmt); 2015 Aug; 24(8):636-40. PubMed ID: 26098552
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive.
Jain JK; Ota F; Mishell DR
Contraception; 2000 Mar; 61(3):195-8. PubMed ID: 10827333
[TBL] [Abstract][Full Text] [Related]
19. Progress in contraception: new technology.
Linn ES
Int J Fertil Womens Med; 2003; 48(4):182-91. PubMed ID: 13677551
[TBL] [Abstract][Full Text] [Related]
20. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
Harkins GJ; Davis GD; Dettori J; Hibbert ML; Hoyt RA
J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
